scispace - formally typeset
M

Michihisa Jougasaki

Researcher at Mayo Clinic

Publications -  96
Citations -  10765

Michihisa Jougasaki is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Natriuretic peptide & Brain natriuretic peptide. The author has an hindex of 45, co-authored 96 publications receiving 10528 citations. Previous affiliations of Michihisa Jougasaki include Kyoto University & Kumamoto University.

Papers
More filters
Journal ArticleDOI

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

TL;DR: Results indicate that BNP is a novel cardiac hormone secreted predominantly from the ventricle, and that the synthesis, secretion and clearance of BNP differ from those of ANP, suggesting discrete physiological and pathophysiological roles of HBNP in a dual natriuretic peptide system.
Journal ArticleDOI

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

TL;DR: Examination of the sources and mechanisms of the secretion of BNP in comparison with those of ANP in control subjects and in patients with heart failure concludes that BNP is secreted mainly from the left ventricle in normal adult humans as well as in Patients with left ventricular dysfunction.
Journal ArticleDOI

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

TL;DR: It is concluded that plasma levels of BNP mainly reflect the degree of ventricular overload and that the secretion patterns of ANP and BNP vary with underlying cardiac disorders of CHF with different degrees of overload in atria and ventricles.
Journal ArticleDOI

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.

TL;DR: It is concluded that the plasma level of brain natriuretic peptide is increased markedly in patients with acute myocardial infarction and may reflect the degree of left ventricular dysfunction in these patients.
Journal ArticleDOI

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

TL;DR: An elevated plasma BNP was a more powerful marker ofleft ventricular systolic dysfunction, left ventricular diastolic function and left vent cardiac hypertrophy than C-terminal ANP or N-terminAL ANP-(1-30) in this population of patients with suspected cardiac disease.